# Comparative Bioavailability Study of Tablet and Granule Formulations of ADC189 and the Study of Ultra-high Dose

> **NCT06428903** · PHASE1 · COMPLETED · sponsor: **Jiaxing AnDiCon Biotech Co.,Ltd** · enrollment: 48 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** ADC189 tablet
- **DRUG:** ADC189 granules
- **DRUG:** ADC189 180mg

## Key facts

- **NCT ID:** NCT06428903
- **Lead sponsor:** Jiaxing AnDiCon Biotech Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-12
- **Primary completion:** 2024-09-22
- **Final completion:** 2024-09-22
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2025-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06428903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06428903, "Comparative Bioavailability Study of Tablet and Granule Formulations of ADC189 and the Study of Ultra-high Dose". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06428903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*